Silence Therapeutics (SLN) Earnings Date & Reports
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
SLN is expected to report earnings to rise 5.73% to -15 cents per share on March 18
Q4'25
Est.
$-0.16
Q3'25
Beat
by $0.04
Q2'25
Missed
by $0.06
Q1'25
Beat
by $0.20
Q3'23
Beat
by $0.10
The last earnings report on November 06 showed earnings per share of -15 cents, beating the estimate of -18 cents. With 224.40K shares outstanding, the current market capitalization sits at 226.72M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLN showed earnings on November 06, 2025. You can read more about the earnings report here.